| Role of MAP kinase in tumor progression and invasion KB Reddy, SM Nabha, N Atanaskova Cancer and Metastasis Reviews 22, 395-403, 2003 | 640 | 2003 |
| Two phase 3 trials of baricitinib for alopecia areata B King, M Ohyama, O Kwon, A Zlotogorski, J Ko, NA Mesinkovska, ... New England Journal of Medicine 386 (18), 1687-1699, 2022 | 256 | 2022 |
| Temporal and quantitative regulation of mitogen-activated protein kinase (MAPK) modulates cell motility and invasion JS Krueger, VG Keshamouni, N Atanaskova, KB Reddy Oncogene 20 (31), 4209-4218, 2001 | 229 | 2001 |
| A preliminary observation: Male pattern hair loss among hospitalized COVID-19 patients in Spain-A potential clue to the role of androgens in COVID-19 severity A Goren, S Vano-Galvan, CG Wambier, J McCoy, A Gomez-Zubiaur, ... J Cosmet Dermatol 19 (7), 1545-1547, 2020 | 216 | 2020 |
| MAP kinase/estrogen receptor cross-talk enhances estrogen-mediated signaling and tumor growth but does not confer tamoxifen resistance N Atanaskova, VG Keshamouni, JS Krueger, JA Schwartz, F Miller, ... Oncogene 21 (25), 4000-4008, 2002 | 156 | 2002 |
| A systematic review of topical finasteride in the treatment of androgenetic alopecia in men and women SW Lee, M Juhasz, P Mobasher, C Ekelem, NA Mesinkovska Journal of drugs in dermatology: JDD 17 (4), 457, 2018 | 139 | 2018 |
| The effect of patch testing on surgical practices and outcomes in orthopedic patients with metal implants NA Mesinkovska, A Tellez, L Molina, G Honari, A Sood, W Barsoum, ... Archives of Dermatology 148 (6), 687-693, 2012 | 112 | 2012 |
| Complementary and alternative treatments for alopecia: a comprehensive review AM Hosking, M Juhasz, N Atanaskova Mesinkovska Skin appendage disorders 5 (2), 72-89, 2019 | 108 | 2019 |
| Hair: What is New in Diagnosis and Management?: Female Pattern Hair Loss Update: Diagnosis and Treatment NA Mesinkovska, WF Bergfeld Dermatologic clinics 31 (1), 119-127, 2013 | 100 | 2013 |
| Efficacy and safety of the oral Janus kinase inhibitor baricitinib in the treatment of adults with alopecia areata: phase 2 results from a randomized controlled study B King, J Ko, S Forman, M Ohyama, N Mesinkovska, G Yu, J McCollam, ... Journal of the American Academy of Dermatology 85 (4), 847-853, 2021 | 96 | 2021 |
| Topical ketoconazole: a systematic review of current dermatological applications and future developments FD Choi, MLW Juhasz, NA Mesinkovska Journal of Dermatological Treatment, 2019 | 94 | 2019 |
| Characterizing the adverse dermatologic effects of hydroxychloroquine: a systematic review AN Sharma, NA Mesinkovska, T Paravar Journal of the American Academy of Dermatology 83 (2), 563-578, 2020 | 92 | 2020 |
| The banned sunscreen ingredients and their impact on human health: a systematic review S Suh, C Pham, J Smith, NA Mesinkovska International journal of dermatology 59 (9), 1033-1042, 2020 | 88 | 2020 |
| Clinical efficacy of diphenylcyclopropenone in alopecia areata: retrospective data analysis of 50 patients KS Chiang, NA Mesinkovska, MP Piliang, WF Bergfeld Journal of Investigative Dermatology Symposium Proceedings 17 (2), 50-55, 2015 | 84 | 2015 |
| Topical Janus kinase inhibitors: a review of applications in dermatology AM Hosking, M Juhasz, NA Mesinkovska Journal of the American Academy of Dermatology 79 (3), 535-544, 2018 | 82 | 2018 |
| The art of prevention: COVID-19 vaccine preparedness for the dermatologist☆,☆☆ SM Rice, SD Ferree, NA Mesinkovska, AS Kourosh International journal of women's dermatology 7 (2), 209-212, 2021 | 69 | 2021 |
| The Alopecia Areata Investigator Global Assessment scale: a measure for evaluating clinically meaningful success in clinical trials KW Wyrwich, H Kitchen, S Knight, NVJ Aldhouse, J Macey, FP Nunes, ... British Journal of Dermatology 183 (4), 702-709, 2020 | 65 | 2020 |
| “‘You lose your hair, what’s the big deal?’ I was so embarrassed, I was so self-conscious, I was so depressed:” a qualitative interview study to understand the … NVJ Aldhouse, H Kitchen, S Knight, J Macey, FP Nunes, Y Dutronc, ... Journal of patient-reported outcomes 4 (1), 76, 2020 | 64 | 2020 |
| 5-alpha-reductase inhibitors are associated with reduced frequency of COVID-19 symptoms in males with androgenetic alopecia FA Cadegiani, S Herrera | 63 | 2021 |
| Efficacy and safety of ritlecitinib in adults and adolescents with alopecia areata: a randomised, double-blind, multicentre, phase 2b–3 trial B King, X Zhang, WG Harcha, JC Szepietowski, J Shapiro, C Lynde, ... The Lancet 401 (10387), 1518-1529, 2023 | 62 | 2023 |
